This review examines recent developments in AI-based TK parameterization with relevance to environmental exposure assessment and discusses current limitations and future perspectives, including model reliability, interpretability, data availability for environmental chemicals, and integrating AI-predicted TK parameters into mechanistic models.
Abstract
Toxicokinetics (TK) characterizes the absorption, distribution, metabolism, and excretion (ADME) of chemicals in the body and connects exposure with internal dose and potential toxicity. Because in vivo and in vitro TK assays are costly and low-throughput, and demand for emerging chemicals is growing, artificial intelligence and machine learning (AI/ML) offer alternative tools to predict ADME profiles for data-poor chemicals. This review examines recent developments in AI-based TK parameterization with relevance to environmental exposure assessment. First, we outline the essential elements of AI-based TK parameterization paradigms, including data sources, molecular representations, and commonly used ML algorithms. Second, the recent applications of AI/ML models across four ADME processes are introduced. Third, we discuss current limitations and future perspectives, including model reliability, interpretability, data availability for environmental chemicals, and integrating AI-predicted TK parameters into mechanistic models, such as physiologically based pharmacokinetic (PBPK) models and other downstream modeling frameworks. Although many existing studies rely on pharmaceutical or mixed chemical datasets, these approaches could support TK parameterization and exposure assessment for environmental chemicals. Further progress will depend on improved data quality, broader environmental chemical coverage, and more rigorous model validation and uncertainty evaluation.
The regulatory-readiness framework is expanded to incorporate OECD QSAR validation principles, chemical data curation, descriptor generation, applicability-domain assessment, scaffold-aware and prospective validation, explainability beyond SHAP, calibrated uncertainty analysis and AOP-linked mechanistic interpretation.
The significance of AI-based toxicogenomics in drug development, environmental contaminant screening, and regulatory toxicology, while addressing key challenges such as data heterogeneity, model interpretability, and regulatory acceptance is discussed.
Mohammed Monirul Islam, Sibghatullah Muhammad Ali Sangi, Girish Meravanige et al.· Frontiers in Genetics· 0 citations
Predictive artificial intelligence applications in pollutant hazard assessment, environmental monitoring, exposure modeling, multi-omics integration, and regulatory decision support are examined.
Ehsan Ghassemi Barghi, F. Motafeghi, Jafar Gholami Gharab et al.· Discover Artificial Intellig...· 0 citations
The accurate prediction of chemical toxicity remains a major challenge in drug development and chemical safety assessment because conventional approaches can be costly, time-consuming, ethically constrained, and limited in predictive performance. This review examines how artificial intelligence (AI), particularly machi...
Ahmed Hagag, Nada A. Elsayed, Ibrahim Abdelbaky· Frontiers in Bioinformatics· 0 citations
Toxicity remains a leading cause of late-stage attrition in drug development and is heavily influenced by a compound’s ADME (Absorption, Distribution, Metabolism, and Excretion) properties. The ability of a molecule to reach its target tissue, persist in circulation, or undergo bioactivation fundamentally shapes its...
Pranav Shah, C. Weber, Nivedita Kinatukara et al.· Scientific Reports· 0 citations
Pharmacological and toxicological assessments of a wide array of chemicals typically involve estimating human clearance through allometric extrapolation of in vivo animal data, using empirical compartmental and physiologically based pharmacokinetic (PBPK) models. Parameters for pharmacokinetic absorption, distribution,...
H. Yamazaki· Yakugaku Zasshi-journal of T...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.